FEMASYS INC
FEMASYS INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1 | 5 | 9 | 5 | 3 | 4 | 3 | 8 | 14 | 18 | 22 | 9 | |||||
Accounts Receivable Net Current | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | 6 | 6 | 6 | 6 | 5 | 4 | 3 | 2 | 1 | 1 | 1 | 1 | |||||
Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets Current | 8 | 12 | 16 | 12 | 10 | 9 | 8 | 11 | 16 | 20 | 23 | 10 | |||||
Property Plant And Equipm… | |||||||||||||||||
Leasehold Improvements Gross | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Property Plant And Equipment Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Furniture And Fixtures Gross | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Machinery And Equipment Gross | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Construction In Progress Gross | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Property Plant And Equipment Gross | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Accumulated Depreciation Depletion And Amortizatio… | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | |||||
Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | |||||
Assets Noncurrent | |||||||||||||||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 2 | 2 | 2 | - | - | - | 2 | - | |||||
Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets Noncurrent Other Than Noncurrent Investment… | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Assets | 12 | 16 | 21 | 16 | 14 | 13 | 12 | 16 | 20 | 24 | 28 | 15 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 2 | 2 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Notes Payable Current | - | - | - | 0 | - | - | - | - | - | - | 0 | 0 | |||||
Convertible Notes Payable Current | - | - | 0 | - | 6 | 6 | 5 | - | - | - | 0 | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 1 | 1 | 1 | - | - | - | 0 | - | |||||
Liabilities Current | 4 | 3 | 4 | 11 | 11 | 10 | 9 | 3 | 2 | 2 | 3 | 2 | |||||
Liabilities Noncurrent | |||||||||||||||||
Convertible Long Term Notes Payable | - | - | 3 | - | - | - | 0 | 5 | 5 | 4 | 4 | - | |||||
Derivative Liabilities Noncurrent | 0 | 1 | 5 | - | - | - | 0 | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 2 | - | - | - | 2 | - | |||||
Liabilities Noncurrent | 4 | 6 | 11 | 1 | 1 | 1 | 2 | 7 | 7 | 6 | 6 | 2 | |||||
Liabilities | 8 | 9 | 15 | 12 | 12 | 11 | 10 | 10 | 9 | 9 | 9 | 4 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Warrants And Rights Outstanding | 6 | 5 | 5 | 7 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 2 | |||||
Additional Paid In Capital | 148 | 147 | 146 | 140 | 137 | 133 | 128 | 125 | 125 | 125 | 124 | 113 | |||||
Retained Earnings Accumulated Deficit | -149 | -145 | -146 | -142 | -138 | -133 | -127 | -122 | -117 | -112 | -108 | -104 | |||||
Stockholders Equity | 4 | 7 | 6 | 5 | 2 | 2 | 2 | 6 | 11 | 16 | 18 | 10 | |||||
Liabilities And Stockholders Equity | 12 | 16 | 21 | 16 | 14 | 13 | 12 | 16 | 20 | 24 | 28 | 15 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |||||
Common Stock Shares Issued | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Shares Outstanding | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.00% | -55.81% | -56.86% | - | - | - | - | - | - | - | - | - |
| 2025 | -23.48% | -14.78% | -21.74% | -60.25% | -59.69% | -29.12% | -2.00% | -29.06% | -40.42% | -3.10% | 4.29% | -51.90% |
| 2024 | -7.09% | -10.24% | -10.24% | 36.05% | 30.23% | 47.67% | 8.74% | 8.74% | 14.56% | -7.12% | -20.60% | -33.41% |
| 2023 | - | - | - | - | - | - | -4.41% | 1.08% | -16.13% | -14.84% | -18.06% | -34.52% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.14 | 3.91 | 4.53 | 1.16 | 0.89 | 0.93 | 0.93 | 3.94 | 6.47 | 8.43 | 7.59 | 4.68 | |||||
| Quick Ratio | 0.55 | 1.98 | 2.95 | 0.61 | 0.41 | 0.54 | 0.58 | 3.26 | 5.93 | 8.02 | 7.37 | 4.40 | |||||
| Working Capital | 4.45M | 9.19M | 12.82M | 1.71M | -1.21M | -708.87K | -560.42K | 8.43M | 13.47M | 17.53M | 20.12M | 8.04M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 2.05 | 1.26 | 2.53 | 2.58 | 8.14 | 5.65 | 4.40 | 1.61 | 0.80 | 0.56 | 0.51 | 0.42 | |||||
| Interest Coverage TTM | -13.48 | -10.17 | -9.30 | -9.20 | -10.61 | -11.63 | -11.09 | -13.28 | -18.04 | -28.42 | -87.72 | -950.11 | |||||
| Debt Ratio | 0.67 | 0.56 | 0.72 | 0.72 | 0.89 | 0.85 | 0.81 | 0.62 | 0.45 | 0.36 | 0.34 | 0.30 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.18 | 0.16 | 0.14 | 0.13 | 0.11 | 0.09 | 0.08 | 0.08 | 0.05 | 0.05 | 0.05 | 0.06 | |||||
| Days Sales Outstanding TTM | 32.19 | 31.16 | 87.93 | 84.14 | 33.57 | 38.03 | 65.79 | 69.76 | 47.69 | 42.53 | 30.03 | 47.86 | |||||
| Receivables Turnover TTM | 11.34 | 11.71 | 4.15 | 4.34 | 10.87 | 9.60 | 5.55 | 5.23 | 7.65 | 8.58 | 12.16 | 7.63 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -3.66 | -3.18 | -9.42 | -9.66 | -14.55 | -16.79 | -16.90 | -16.29 | -15.03 | -13.69 | -18.52 | -16.87 | |||||
| Free Cash Flow Per Share TTM | -5.62 | -5.58 | -9.72 | -7.42 | -10.74 | -16.25 | -18.15 | -16.29 | -13.60 | -12.31 | -14.85 | -14.98 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 60.95% | 61.56% | 61.96% | 63.05% | 65.09% | 66.24% | 66.55% | 65.83% | 65.67% | 65.35% | 64.54% | 64.57% | |||||
| Operating Profit Margin TTM | -763.90% | -687.93% | -766.95% | -858.04% | -1,015.00% | -1,164.28% | -1,091.75% | -1,389.19% | -1,734.10% | -1,423.03% | -1,353.43% | -1,194.70% | |||||
| Net Profit Margin TTM | -534.27% | -521.78% | -812.27% | -960.53% | -1,113.68% | -1,242.56% | -1,155.03% | -1,436.04% | -1,756.82% | -1,420.27% | -1,329.06% | -1,164.65% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 21.86% | 39.88% | 40.77% | 63.53% | 98.61% | 61.97% | 51.97% | 15.33% | -20.57% | -11.00% | -11.13% | -29.75% | |||||
| Net Income Growth (1Y) | -41.54% | -41.26% | -1.00% | 9.38% | 25.90% | 41.70% | 32.07% | 42.20% | 42.46% | 30.05% | 25.04% | 0.28% | |||||
| EPS Growth (1Y) | -74.85% | -77.83% | -44.26% | -40.71% | -3.15% | 22.69% | -8.75% | -3.46% | -15.95% | -29.09% | -3.97% | -21.51% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1.14 | -2.26 | -1.22 | -0.73 | -1.33 | -1.49 | -1.30 | -1.36 | -1.52 | -2.27 | -1.05 | -3.53 | |||||
| P/B TTM | 3.48 | 3.84 | 3.88 | 3.17 | 18.51 | 15.74 | 10.63 | 4.13 | 2.25 | 2.16 | 0.82 | 4.31 | |||||
| P/S TTM | 6.10 | 11.78 | 9.93 | 7.00 | 14.78 | 18.50 | 15.04 | 19.58 | 26.66 | 32.17 | 13.99 | 41.15 | |||||
| Market Cap | 14.03M | 27.99M | 22.78M | 14.44M | 27.90M | 31.44M | 24.49M | 24.68M | 25.33M | 33.75M | 15.00M | 44.98M | |||||
| Enterprise Value | 12.59M | 22.61M | 16.69M | 10.14M | 30.76M | 33.38M | 26.45M | 22.14M | 16.56M | 20.39M | -2.46M | 36.57M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -18.85M | -18.58M | -19.22M | -15.21M | -15.52M | -20.43M | -20.21M | -18.11M | -15.11M | -13.40M | -11.42M | -11.31M | |||||
| Net Debt | -1.44M | -5.39M | -6.09M | -4.29M | 2.86M | 1.94M | 1.95M | -2.54M | -8.77M | -13.36M | -17.46M | -8.41M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
FEMASYS INC (FEMY) — SEC Financial Statements & Analysis
FEMASYS INC (FEMY) is a surgical & medical instruments & apparatus company, incorporated in DE. FEMASYS INC trades on Nasdaq as: FEMY. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), FEMASYS INC reported a 21.86% year-over-year revenue growth, a Gross Profit Margin of 60.95% (TTM), a Debt-to-Equity ratio of 2.05x, a Price-to-Sales (P/S) ratio of 6.10x (TTM), a Price-to-Book (P/B) ratio of 3.48x (TTM), at a market cap of $14.03M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 21.86%
- Gross Profit Margin TTM
- 60.95%
- Debt To Equity
- 2.05x
- P/S TTM
- 6.10x
- P/B TTM
- 3.48x
- Market Cap
- $14.03M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is FEMASYS INC in?
FEMASYS INC (FEMY) operates in the Surgical & Medical Instruments & Apparatus industry.
What is FEMY's market cap?
FEMASYS INC (FEMY) has a market capitalization of $14.03M as of 2026-06-30.
What exchange does FEMY trade on?
FEMASYS INC (FEMY) trades on the Nasdaq.
Where is FEMASYS INC incorporated?
FEMASYS INC is incorporated in DE.